Contrast-induced nephropathy in percutaneous coronary intervention: Clinical case report
DOI:
https://doi.org/10.35622/j.ram.2022.04.005Keywords:
contrast nephropathy, dialysis, kidney injury, percutaneous coronary interventionAbstract
Contrast-induced nephropathy (CIN) is the third leading cause of in-hospital acute kidney injury. Although most cases are self-limiting and renal function returns to normal within 1-3 weeks, short-term or long-term complications such as chronic renal failure, the need for dialysis therapy, and even death. Here we present a case of a patient with ischemic heart disease, valvular injury who underwent percutaneous coronary intervention. It was concluded that the preventive measures that have shown greater effectiveness are: intravascular volume expansion (hydration), withdrawal of nephrotoxic drugs and determining that the contrast medium is of low osmolarity.
References
Loforte DL, Jiménez YV, González AH, Blanco SR, López AG, Díaz IM. Evaluación de pacientes con nefropatía inducida por contraste posterior a la angioplastia coronaria transluminal percutánea. Acta Médica [Internet]. 4 de mayo de 2021 [citado 15 de mayo de 2021];22(1). Disponible en:http://www.revactamedica.sld.cu/index.php/act/article/view/108
Villalón DXC, Moreno DYRB, Mirabal DGG, Carrillo DAM, Pouymiro DSH, Romero LJLG. Nefropatía inducida por contraste en la cardiología intervencionista. Rev Cuba Cardiol Cir Cardiovasc. 27 de octubre de 2017;23(3):387-99. https://cutt.ly/UByXaWY
Loforte DL, Jiménez YV, González AH, Blanco SR, López AG, Díaz IM. Evaluación de pacientes con nefropatía inducida por contraste posterior a la angioplastia coronaria transluminal percutánea. Acta Médica. :15.http://www.revactamedica.sld.cu/index.php/act/article/view/108
Waheed S, Choi MJ. Trials and tribulations of diagnosing and preventing contrast- induced acute kidney injury. J Thorac Cardiovasc Surg. noviembre de 2021;162(5):1581-6. DOI: 10.1016/j.jtcvs.2020.06.147
Aksoy F, Aydın Baş H, Bağcı A, Basri Savaş H. Predictive value of oxidant and antioxidant status for contrast-induced nephropathy after percutaneous coronary intervention for ST-segment elevation myocardial infarction. Rev Port Cardiol. julio de 2021;40(7):489-97. DOI: 10.1016/j.repce.2021.07.018
Actualidad en nefropatía por medio de contraste [Internet]. [citado 15 de mayo de 2021]. Disponible en: https://www.elsevier.es/es-revista-nefrologia-latinoamericana-265-pdf-S2444903217300185
Cardoso PP. Contrast-induced nephropathy: Can we better predict and prevent it? Rev Port Cardiol. julio de 2021;40(7):499-500. DOI: 10.1016/j.repce.2021.07.019
Gaitan Esteban Sanchez, Ampudia Margarita Malpartida. Revista médica sinergia [Internet]. editorial medica esculapio; [citado 15 de mayo de 2021]. Disponible en: https://revistamedicasinergia.com/index.php/rms/article/view/586/977 https://doi.org/10.31434/rms.v5i10.586
He Y, Deng Y, Zhuang K, Li S, Xi J, Chen J. Predictive value of cystatin C and neutrophil gelatinase-associated lipocalin in contrast-induced nephropathy: A meta-analysis. PLoS ONE. 2 de abril de 2020;15(4):e0230934. https://doi.org/10.1371/journal.pone.0230934
Spineti PP de M. Qual o Papel dos Biomarcadores de Lesão Renal na Nefropatia Induzida por Contraste? Arq Bras Cardiol. 8 de junio de 2021;116(6):1057-8. DOI: 10.36660/abc.20210433
Korolov Y, Nogués I, Jimena Gambarte M, Sol Donato M, Graciana Ciambrone M, Novo F, et al. Microalbuminuria predicts contrast-induced nephropathy in patients with acute coronary syndrome. REC Interv Cardiol Engl Ed. 7 de julio de 2022;4337. DOI: https://doi.org/10.24875/RECICE.M20000139
Çınar T, Tanık VO, Aruğaslan E, Karabağ Y, Çağdaş M, Rencüzoğulları İ, et al. The association of PRECISE-DAPT score with development of contrast-induced nephropathy in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Cardiovasc Interv Ther. julio de 2019;34(3):207-15. DOI: 10.1007/s12928-018-0545-6
Mas-Font S, Herrera-Gutiérrez ME, Gómez-González C, Herrera-Rojas D, Montoiro-Allue R, Sánchez-Morán F, et al. Estudio epidemiológico prospectivo sobre la nefropatía por contraste en pacientes críticos. Estudio NEFROCON. Med Intensiva. noviembre de 2021;45(8):e31-3. https://doi.org/10.1016/j.medin.2020.07.004
Liu Y, Hong D, Wang AY, Guo R, Smyth B, Liu J, et al. Effects of intravenous hydration on risk of contrast induced nephropathy and in-hospital mortality in STEMI patients undergoing primary percutaneous coronary intervention: a systematic review and meta-analysis of randomized controlled trials. BMC Cardiovasc Disord. diciembre de 2019;19(1):87. DOI: 10.1186/s12872-019-1054-y
Moitinho MS, Santos ES, Caixeta AM, Belasco AG da S, Barbosa DA, Fonseca CD da. Contrast-Induced Nephropathy in patients submitted to percutaneous coronary intervention: an integrative review. Rev Bras Enferm. 2020;73(suppl 5):e20200190. https://doi.org/10.1590/0034-7167-2020-0190
Liu Y, Tan N, Huo Y, Chen S, Liu J, Chen YD, et al. Hydration for prevention of kidney injury after primary coronary intervention for acute myocardial infarction: a randomised clinical trial. Heart. 1 de junio de 2022;108(12):948-55. DOI: 10.1136/heartjnl-2021-319716
ESUR_Guidelines_10.0_Final_Version_SPANISH.pdf [Internet]. [citado 17 de mayo de 2021]. Disponible en: https://cutt.ly/bByZKC8
de Paiva Cavalcante AT. REAÇÕES ADVERSAS RENAIS: INJÚRIA RENAL AGUDA PÓSCONTRASTE (IRA-PC) E NEFROPATIA INDUZIDA PELO CONTRASTE (NIC). En: Departamento de Radiologia da Irmandade da Santa Casa de Misericórdia de São Paulo, Garbugio Dutra B, Bauab Jr. T, Departamento de Radiologia da Clínica Mama Imagem, editores. MEIOS DE CONTRASTE Conceitos e diretrizes [Internet]. 1.a ed. Farol Editora; 2020 [citado 20 de mayo de 2021]. p. 85-119. Disponible en: https://manual.spr.org.br/meios-de-contraste-cap4 https://doi.org/10.6018/eglobal.18.4.360651
Vega F, Múgica MV, Argíz L, Bazire R, Belver MT, Friera A, et al. Protocol to prevent contrast‐induced nephropathy in parenteral challenge tests for allergy evaluation of hypersensitivity reactions to iodinated contrast media. Clin Exp Allergy. octubre de 2020;50(10):1200-3. DOI: 10.1111/cea.13709
Daño renal asociado a uso de medios de contraste [Internet]. MonKeyEM. 2020 [citado 20 de mayo de 2021]. Disponible en: https://cutt.ly/MByZB86
Published
Issue
Section
License
Copyright (c) 2022 Danny Silva, Cesar Arreaga, Fernando Silva, Mirella Barrera, Velimir Flores, Juan Salazar, Diana Salazar, Ernesto Kang, Flavia Camacho, Linda Quintero
This work is licensed under a Creative Commons Attribution 4.0 International License.
